gm-csf standard abts elisa development kit Search Results


96
Cellular Technology Ltd human gm csf
Human Gm Csf, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/us10086067-41-4-51?v=Cellular+Technology+Ltd
Average 96 stars, based on 1 article reviews
human gm csf - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
CellSystems Biotechnologie Vertrieb GmbH methylcellulose plates methocult gf h4535
Methylcellulose Plates Methocult Gf H4535, supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/us08309608-52-27-45?v=CellSystems+Biotechnologie+Vertrieb+GmbH
Average 90 stars, based on 1 article reviews
methylcellulose plates methocult gf h4535 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

94
R&D Systems csf2 elisa
<t>CSF2,</t> IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.
Csf2 Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pmc13003168-240-13-15?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
csf2 elisa - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

92
Boster Bio gm csf
<t>CSF2,</t> IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.
Gm Csf, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pm40246882-384-0-20?v=Boster+Bio
Average 92 stars, based on 1 article reviews
gm csf - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cytokines (mouse recombinant scf, gm-csf, il3, il6, il7)
<t>CSF2,</t> IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.
Cytokines (Mouse Recombinant Scf, Gm Csf, Il3, Il6, Il7), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pmc08320641-48-19-30?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
cytokines (mouse recombinant scf, gm-csf, il3, il6, il7) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Bio-Techne corporation human gm-csf quantikine elisa kit
<t>CSF2,</t> IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.
Human Gm Csf Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/custom%40dgm00%4035568783?v=Bio-Techne+corporation
Average 93 stars, based on 1 article reviews
human gm-csf quantikine elisa kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Bio-Techne corporation mouse gm-csf quantikine elisa kit
<t>CSF2,</t> IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.
Mouse Gm Csf Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/custom%40mgm00%4036453584?v=Bio-Techne+corporation
Average 94 stars, based on 1 article reviews
mouse gm-csf quantikine elisa kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
R&D Systems elisa kit
<t>CSF2,</t> IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.
Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pmc04203548-387-1-4?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
R&D Systems human gm csf duoset elisa development kit
Effect of IL-1 β and TNF α on M-CSF, IL-34, and GM-CSF expression in RA SF . SF were stimulated by IL-1 β (25 ng/mL) or TNF α (25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are given as the relative expression using hHPRT gene as housekeeping gene. The bars represent the mean and each plots one biological replicate ( n = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by <t>ELISA.</t> Results are given as the mean (± SEM). * P < 0.05; ** P < 0.001; *** P < 0.0001.
Human Gm Csf Duoset Elisa Development Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pmc04251793-77-12-18?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
human gm csf duoset elisa development kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
OriGene gm csf shrna plasmid
Effect of IL-1 β and TNF α on M-CSF, IL-34, and GM-CSF expression in RA SF . SF were stimulated by IL-1 β (25 ng/mL) or TNF α (25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are given as the relative expression using hHPRT gene as housekeeping gene. The bars represent the mean and each plots one biological replicate ( n = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by <t>ELISA.</t> Results are given as the mean (± SEM). * P < 0.05; ** P < 0.001; *** P < 0.0001.
Gm Csf Shrna Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pmc04102645-73-0-15?v=OriGene
Average 90 stars, based on 1 article reviews
gm csf shrna plasmid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Jackson Laboratory male nsg sgm3
Effect of IL-1 β and TNF α on M-CSF, IL-34, and GM-CSF expression in RA SF . SF were stimulated by IL-1 β (25 ng/mL) or TNF α (25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are given as the relative expression using hHPRT gene as housekeeping gene. The bars represent the mean and each plots one biological replicate ( n = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by <t>ELISA.</t> Results are given as the mean (± SEM). * P < 0.05; ** P < 0.001; *** P < 0.0001.
Male Nsg Sgm3, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pmc12597918-151-3-15?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
male nsg sgm3 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Charles River Laboratories nod scid gamma nsg s mice
Effect of IL-1 β and TNF α on M-CSF, IL-34, and GM-CSF expression in RA SF . SF were stimulated by IL-1 β (25 ng/mL) or TNF α (25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are given as the relative expression using hHPRT gene as housekeeping gene. The bars represent the mean and each plots one biological replicate ( n = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by <t>ELISA.</t> Results are given as the mean (± SEM). * P < 0.05; ** P < 0.001; *** P < 0.0001.
Nod Scid Gamma Nsg S Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm-csf+standard+abts+elisa+development+kit/pm39536753-225-4-12?v=Charles+River+Laboratories
Average 86 stars, based on 1 article reviews
nod scid gamma nsg s mice - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


CSF2, IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.

Journal: Glia

Article Title: Inflammatory Mediators Both Directly and Indirectly Promote Microglial Proliferation

doi: 10.1002/glia.70150

Figure Lengend Snippet: CSF2, IL3, and TNFɑ, but not other screened factors, boost microglial proliferation. (A) Schematic representation for microglial immunopanning, culture, and treatment. (B) Bar plot depicting the fold change in percentage of proliferative microglia in response to each screened factor at 10 ng/mL relative to the MGM control. (C) Representative images of CSF2, IL3, or TNFɑ induced microglial proliferation. (D) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL CSF2. (E) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL IL3. (F) Bar plot depicting the percentage of proliferative microglia in response to 10 ng/mL TNFɑ. (B): N = 3 independent microglial cultures with treatment in triplicate; (D–F): N = 9–12 wells across 3–4 independent microglial cultures. Bars represent mean ± SEM. B: One‐way ANOVA, Dunnett's post hoc comparing fold changes to mean MGM control; (D–F): Unpaired t ‐test; Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar = 50 μm. BDNF, Brain‐derived neurotrophic factor; CSF, Colony stimulating factor; CX3CL1, Fractalkine; IFN, Interferon; IGF, Insulin‐like growth factor; IL, Interleukin; LPA, Lysophosphatidic acid; MGM, Microglia growth media; NGF, Nerve growth factor β; NRG1, Neuregulin 1; NT3, Neurotrophin 3; NTS, Neurotensin; S1P, Sphingosine‐1 phosphate; SCF, Stem cell factor; TNFɑ, Tumor necrosis factor ɑ; VEGF, Vascular endothelial growth factor; WNT3a, Wingless‐related int‐3a.

Article Snippet: To determine the concentration of CSF2 in our concentrated ACM, we performed a CSF2 ELISA (R&D Systems MGM00) as per the manufacturer's instructions.

Techniques: Control, Derivative Assay

Astrocyte‐secreted CSF2 promotes microglial proliferation in response to IL1ɑ and IL1β stimulation. (A) Plot depicting the percentage of proliferative microglia following 10 ng/mL treatment with each elevated cytokine identified by cytokine assay in microglia media lacking CSF1 and TGFβ2. (B) Plot depicting the concentration of CSF2 protein as determined by ELISA in 50× concentration ACM, IL1ɑ and IL1β ACM. (C) Representative images of 50× concentrated IL1ɑ ACM and IL1β ACM induced microglial proliferation (red = CD11b; white = KI67) and CSF2 neutralization. (D) Plot depicting the percentage of proliferative microglia in response to 50× concentrated UCM, ACM, IL1ɑ ACM with either IgG2A isotype control or ɑCSF2 treatment. (E) Plot depicting the percentage of proliferative microglia in response to 50× concentrated UCM, ACM, IL1β ACM with either IgG2A isotype control or ɑCSF2 treatment. Bars represent mean ± SEM. A: N = 12 wells from 3 independent cultures; (B): N = 4 batches of ACM; (D‐E): N = 9 wells from 3 independent cultures, the same AUCM and ACM controls were used for each of these experiments as they were prepared and tested alongside each respective IL1 ACM. (A, C, D): Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. (A, B, D, E): One‐way ANOVA, Tukey's post hoc to compare differences between all conditions, * p < 0.05. Scale bars = 50 μm. ACM, Astrocyte conditioned media; CSF, Colony stimulating factor; CXCL, C‐X‐C motif chemokine ligand; CX3CL1, Fractalkine; IL, Interleukin; UCM, Unconditioned media.

Journal: Glia

Article Title: Inflammatory Mediators Both Directly and Indirectly Promote Microglial Proliferation

doi: 10.1002/glia.70150

Figure Lengend Snippet: Astrocyte‐secreted CSF2 promotes microglial proliferation in response to IL1ɑ and IL1β stimulation. (A) Plot depicting the percentage of proliferative microglia following 10 ng/mL treatment with each elevated cytokine identified by cytokine assay in microglia media lacking CSF1 and TGFβ2. (B) Plot depicting the concentration of CSF2 protein as determined by ELISA in 50× concentration ACM, IL1ɑ and IL1β ACM. (C) Representative images of 50× concentrated IL1ɑ ACM and IL1β ACM induced microglial proliferation (red = CD11b; white = KI67) and CSF2 neutralization. (D) Plot depicting the percentage of proliferative microglia in response to 50× concentrated UCM, ACM, IL1ɑ ACM with either IgG2A isotype control or ɑCSF2 treatment. (E) Plot depicting the percentage of proliferative microglia in response to 50× concentrated UCM, ACM, IL1β ACM with either IgG2A isotype control or ɑCSF2 treatment. Bars represent mean ± SEM. A: N = 12 wells from 3 independent cultures; (B): N = 4 batches of ACM; (D‐E): N = 9 wells from 3 independent cultures, the same AUCM and ACM controls were used for each of these experiments as they were prepared and tested alongside each respective IL1 ACM. (A, C, D): Colors represent independent microglial cultures: Large data points = mean percentage of proliferative microglia per culture, small data points = percentage of proliferative microglia per well. (A, B, D, E): One‐way ANOVA, Tukey's post hoc to compare differences between all conditions, * p < 0.05. Scale bars = 50 μm. ACM, Astrocyte conditioned media; CSF, Colony stimulating factor; CXCL, C‐X‐C motif chemokine ligand; CX3CL1, Fractalkine; IL, Interleukin; UCM, Unconditioned media.

Article Snippet: To determine the concentration of CSF2 in our concentrated ACM, we performed a CSF2 ELISA (R&D Systems MGM00) as per the manufacturer's instructions.

Techniques: Cytokine Assay, Concentration Assay, Enzyme-linked Immunosorbent Assay, Neutralization, Control

Effect of IL-1 β and TNF α on M-CSF, IL-34, and GM-CSF expression in RA SF . SF were stimulated by IL-1 β (25 ng/mL) or TNF α (25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are given as the relative expression using hHPRT gene as housekeeping gene. The bars represent the mean and each plots one biological replicate ( n = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by ELISA. Results are given as the mean (± SEM). * P < 0.05; ** P < 0.001; *** P < 0.0001.

Journal: Mediators of Inflammation

Article Title: IL-1 β and TNF α Promote Monocyte Viability through the Induction of GM-CSF Expression by Rheumatoid Arthritis Synovial Fibroblasts

doi: 10.1155/2014/241840

Figure Lengend Snippet: Effect of IL-1 β and TNF α on M-CSF, IL-34, and GM-CSF expression in RA SF . SF were stimulated by IL-1 β (25 ng/mL) or TNF α (25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are given as the relative expression using hHPRT gene as housekeeping gene. The bars represent the mean and each plots one biological replicate ( n = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by ELISA. Results are given as the mean (± SEM). * P < 0.05; ** P < 0.001; *** P < 0.0001.

Article Snippet: GM-CSF levels were measured in RA SF conditioned media by ELISA assay (Human GM-CSF DuoSet ELISA development kit, R&D Systems).

Techniques: Expressing, Concentration Assay, Enzyme-linked Immunosorbent Assay